Literature DB >> 12417344

Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein.

Jérôme Tauzin1, Laurent Miclo, Jean Luc Gaillard.   

Abstract

Angiotensin-I-converting enzyme (ACE) inhibitory activity of a tryptic digest of bovine alpha(S2)-casein (alpha(S2)-CN) was extensively investigated. Forty-three peptide peaks were isolated and tested. Seven casokinins (i.e. CN-derived ACE inhibitory peptides) were identified and their IC50 values were determined. Four peptides exhibited an IC50 value lower than 20 microM. Peptides alpha(S2)-CN (f174-181) and alpha(S2)-CN (f174-179) had IC50 values of 4 microM. Surprisingly, deletion of the C-terminal dipeptide of two of these casokinins did not significantly alter their inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417344     DOI: 10.1016/s0014-5793(02)03576-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Bioactive peptides of animal origin: a review.

Authors:  Z F Bhat; Sunil Kumar; Hina Fayaz Bhat
Journal:  J Food Sci Technol       Date:  2015-01-21       Impact factor: 2.701

2.  Peptidomic analysis of healthy and subclinically mastitic bovine milk.

Authors:  Andres Guerrero; David C Dallas; Stephanie Contreras; Aashish Bhandari; Angela Cánovas; Alma Islas-Trejo; Juan F Medrano; Evan A Parker; Meng Wang; Kasper Hettinga; Sabrina Chee; J Bruce German; Daniela Barile; Carlito B Lebrilla
Journal:  Int Dairy J       Date:  2015-07-01       Impact factor: 3.032

3.  Impact of sequential enzymatic hydrolysis on antioxidant activity and peptide profile of casein hydrolysate.

Authors:  Priyanka Singh Rao; Rajesh Bajaj; Bimlesh Mann
Journal:  J Food Sci Technol       Date:  2020-05-14       Impact factor: 2.701

4.  Acute dairy milk ingestion does not improve nitric oxide-dependent vasodilation in the cutaneous microcirculation.

Authors:  Billie K Alba; Anna E Stanhewicz; W Larry Kenney; Lacy M Alexander
Journal:  Br J Nutr       Date:  2016-05-16       Impact factor: 3.718

5.  Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species.

Authors:  F Minervini; F Algaron; C G Rizzello; P F Fox; V Monnet; M Gobbetti
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

Review 6.  Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Hamedah Sabbah Alenezi; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-06-18       Impact factor: 4.052

7.  Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities.

Authors:  Margaret W Ndinguri; Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Trista K Robichaud; Gregg B Fields
Journal:  Molecules       Date:  2012-11-30       Impact factor: 4.411

8.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Gábor Á Fülöp; Viktória Csató; Andrea Daragó; Judit Boczán; Emese Bányai; István Elek Szentkirályi; Tamás Miklós Maros; Tamás Szerafin; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

9.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Andrea Daragó; Judit Boczán; Emese Bányai; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

10.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.

Authors:  Miklós Fagyas; Katalin Úri; Ivetta M Siket; Andrea Daragó; Judit Boczán; Emese Bányai; István Édes; Zoltán Papp; Attila Tóth
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.